“…It is well known that almost all patients with EOC receive chemotherapy after initial diagnosis [27]. Some researchers have suggested that the increased incidence of brain metastasis in EOC is related to the effectiveness of chemotherapy [28], or that cisplatin-based chemotherapy may contribute to an increase in the incidence of CNS involvement [29,30], Thus, therapy of brain metastases with combination of surgery, WBRT and chemotherapy, or combination of surgery and WBRT or SRS (stereotactic radiosurgery)/GKRS (gamma-knife radiosurgery) yielded better survival results (median survival of 20, 17, and 18 months, resp.) than therapy of brain metastases with surgery alone, WBRT alone, chemotherapy alone, WBRT and chemotherapy, and no treatment (median survival of 6.7, 4.5, 7.5, 9.1, and 1.4 months, resp.).…”